A double blind controlled study on the antispasmodic effect and the side effect of Padrin composite injection.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000983:Antipyrine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008744:Methylamines / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010919:Placebos; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use*; D011759:Pyrrolidines / Q000009:adverse effects / Q000627:therapeutic use*; D013451:Sulfonic Acids / Q000009:adverse effects / Q000627:therapeutic use
D004338:Drug Combinations; D008744:Methylamines; D010276:Parasympatholytics; D010919:Placebos; D011720:Pyrazoles; D011759:Pyrrolidines; D013451:Sulfonic Acids; D000983:Antipyrine